5 Dividend Picks From Billionaire Stanley Druckenmiller

DUQUESNE CAPITALStanley Druckenmiller founded Duquesne Capital in 1981, but closed his fund in 2010. He continues to manage money and reports his holdings to the SEC quarterly via 13F filings. The most recent third quarter 13F for Druckenmiller showed a couple additions and a number of key increases. We have identified Druckenmiller’s top five dividend paying stocks and will discuss them in more detail below. Here’s his full portfolio.

Three new dividend increases for Druckenmiller’s portfolio were in the pharma space. The manager’s stake in each pharma company was increased by at least 40% during 3Q. Merck & Co., Inc. (NYSE:MRK), after a 43% share increase from 2Q, is now Druckenmiller’s fifth largest 13F holding. Merck is expected to see year-end sales decline due to the patent expiration on its respiratory drug Singulair, and pays a dividend yield of nearly 3.8%.

Although the company has a pipeline of other drugs, we see little value when comparing it to top competitor Pfizer Inc (NYSE:PFE). Merck and Pfizer trade in lockstep on a valuation basis and in terms of dividend yield, but Merck has a debt to equity ratio of 1.5, triple that of Pfizer. With Merck only expected to grow five-year earnings at 5% annually, we believe investors can find better values in pharma. Merck is also a Kahn Brothers’ Top Pick for 3Q.

Pfizer is in the process of selling its nutrition business to Nestle, which should help boost cash to buy back shares and continue to pay its 3.6% dividend yield. The other cash-generating event will be the IPO of 20% of its animal health business.

Eli Lilly & Co. (NYSE:LLY), a 48% increase in 2Q shares owned by Druckenmiller, pays the highest dividend of our three pharma stocks at 4.1%. Eli Lilly is currently trying to execute a fairly new strategy to combat the loss of patent protection on various drugs. Helping counter this loss will be Eli’s entry into Japan and other emerging markets. Eli also has 13 of its 66 drugs in pipeline that are currently under regulatory review and in Phase III trials. The company’s shares also have the lowest valuation of the three pharma stocks mentioned here at 13x earnings, making for quite a value play.

Furthermore, two of Druckenmiller’s remaining top five picks were new additions from the oil and gas industry that also pay top-notch dividends. Exxon Mobil Corporation (NYSE:XOM) was Druckenmiller’s number one stock that made up 6.7% of his firm’s 3Q 13F. Chevron Corporation (NYSE:CVX), also a new pick for Druckenmiller in 3Q, takes the fourth spot in his 13F.

Exxon and Chevron – two giants in the oil and gas industry – trade in line at 9x earnings and both pay solid dividends. The dividend yield on Exxon shares is 2.6%, while Chevron’s yield is 3.4%. As global GDP is expected to grow 2.3% in 2012 and 2.6% in 2013, it should boost demand for both oil and gas.

Exxon plans to target production growth of 1%-2% a year through 2016 with strong downstream operations – namely U.S. refining – and upstream growth opportunities, including increasing its focus on deepwater. Production for Chevron is expected to be 4%-5% from 2014 to 2017 on the back of downstream operations restructuring. Chevron expects to continue acquisitions with a focus on exploring and producing properties. Around 90% of 2012 CapEx is expected to be spent on E&P operations, spread geographically across Asia, the Americas and Africa.

Druckenmiller’s two big oil and gas bets should yield positive results in the long term given their industry-leading positions and strong global growth outlook. Additionally, we prefer Pfizer and Eli Lilly to Merck. The pharma companies mentioned are more advantageous to income investors, compared to the oil and gas companies; each offers a yield of at least 3.6%. Exxon pays the lowest dividend yield of the five stocks, while Chevron pays 3.4%.  Check out all of billionaire Stanley Druckenmiller’s 3Q stocks picks.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!